Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|78|3-4|274-281

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.3-4, 2010-06, pp. : 274-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 134-139

Karger

Access to resources Recommend Favorite

Sequential Administration of Doxorubicin and Paclitaxel Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil Combination (CMF) in Women with Metastatic Breast Cancer

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 533-537

Karger

Access to resources Recommend Favorite

First-Line Monochemotherapy with Mitoxantroneversus Combination with Fluorouracil, Epirubicin and Cyclophosphamide in High-Risk Metastatic Breast Cancer: A Prospective Randomized Multicenter Clinical Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Dose-Dense Sequential Adjuvant Chemotherapy with Epirubicin, Paclitaxel and CMF in High-Risk Breast Cancer

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 185-191

Karger

Access to resources Recommend Favorite